NHS medical and management professionals are making major progress in the constant battle to prevent and control healthcare associated infection (HCAI).
But there is still much to do, with latest infection-figures (for 2018/19) revealing 83,000 cases of E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia, and CDI, affecting 73,000 patients, across England –resulting in more than 12,700 patient deaths (some 16% of infection-cases).
At the same time, stakeholders from all elements of the ‘whole patient pathway’ (hospitals, community-health and the care sector) must also now co-ordinate their crucial contribution to the UK Government’s five-year action plan and 20-year vision for tackling antimicrobial resistance (AMR). Key targets include reducing drug-resistant infections by 10% by 2025, reducing antibiotic use in humans by 15%, and reducing gram-negative blood-stream-infections.
February 2020 will see 500 senior healthcare professionals coming together, at NCC Birmingham, to focus on these major issues and challenges, at NHS England’s annual infection-prevention and control meeting and conference.